database.name

What exists, and how to get in.

NCTN: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma (RTOG-1010)

Getting access

No access information recorded yet.

About this database

Last updated2026-08-25

← Back to the index